Sugar Derivatives TRIZ Cases

Hydrogenation lowers reducing sugars before membrane separation, reducing yellowing risk while producing liquid polyols and concentrated maltitol.

Dual capping selectively addresses amino and hydroxyl groups, raising crude oligonucleotide purity above 70% while reducing byproducts.

Modified ring, sugar, and linkage structures address limitations in existing cyclic dinucleotides by supporting STING activation and type I interferon production.

Carbodiimide-based reactive groups improve quencher stability and efficiency for fluorescence-based nucleic acid detection.

Targeted DNA methylation markers address inadequate risk models by improving breast cancer screening sensitivity and specificity.

Separate transfections complicate mixed rAAV production; one-step plasmid co-transfection controls vector ratios while reducing labor and cost.

Separate pH and ion signals in nucleic acid complexes help map lysosomal chemistry at single-endosome resolution.

Blocking oligonucleotides fill single-stranded regions to create nick-free nanoswitches with greater stability and fewer non-specific interactions.

A saponin-bound protein and an effector-bearing partner target the same tumor epitope, improving delivery while reducing off-target effects.

Compare protein expression from different mRNAs with a shared peptide tag and one antibody, avoiding separate target-specific antibodies.

One antibody measures proteins from different mRNAs through a shared labeling peptide, avoiding target-specific antibody selection.

Binding moieties and polymers help nucleic acid therapies enter cells, remain stable in blood, and limit toxicity and non-specific immune stimulation.

Stable tellurophene mass tags enable cellular-resolution detection of small molecules by mass spectrometry without MC-compatible elements.

Anti-TREM2 antibodies deplete non-stimulatory myeloid cells through ADCC, ADCP, or CDC to restore T-cell activation and improve tumor control.

Novel 5′-phosphoramidite monomers use tailored protecting groups to improve purity and yield in modified oligonucleotide synthesis.

Engineered microorganisms and plant cells produce steviol glycosides directly, reducing pigments, lipids, proteins, and phenolics from stevia extracts.

An engineered yeast pathway omits the problematic GDP-fucose transporter to limit unwanted byproducts while producing high-purity 2′-FL.

Controlled heating, cooling, and filtration simplify rhodamine dye synthesis while supporting purity and lower production costs.

Molecular imprinting positions binding and acid units near glycosidic bonds for selective, recoverable carbohydrate hydrolysis.

Porous copolymer beads expand uniformly in polar and non-polar solvents, increasing reaction area while reducing substrate use.

Traditional RNA modification limits diversity and raises synthesis costs; sulfinate chemistry adds varied functional groups through a flexible platform.

Learn how psicose-based disaccharide precursors convert to allulose by heating with high conversion and minimal by-products.

Centrifugation sends unfiltered supernatant to affinity chromatography, removing depth-filtration steps while preserving biomolecule yield and purity.

Combined enzymatic and chemical synthesis with HPLC purification delivers at least 96% pure GM1 for clear, concentrated aqueous solutions.

Chaotropic buffers and 15–35% isopropanol improve solid-phase binding of short-chain nucleic acids for higher fetal DNA recovery.

Soluble pseudo solid-phase supports shift oligonucleotide synthesis into solution, helping scale-up, manage reagents, and monitor intermediates.

Antisense DGAT2 compounds inhibit nucleic-acid expression to reduce triglyceride synthesis, addressing limited NAFLD treatment efficacy.

A water–organic solvent composition keeps fluorescent probes in solution while suppressing purity loss during long-term storage.

A modified terminal phosphate helps siRNA resist phosphatase hydrolysis while preserving RISC recognition and precise mRNA cleavage.

Ambiguous overlap ligation can create wrong intermediates; asymmetric, multi-tier assembly selects matching partners to build longer targets accurately.

Complex O100 glycosidic linkages are addressed with orthogonal protection, selective assembly, and NMR analysis of absolute configurations.

Small molecules block PF4 tetramerization, disrupting ultra-large complexes that trigger platelet activation in HITT and VITT.

Local distal-intestinal ASBTI action helps lower serum and hepatic bile acids while addressing swallowing and taste barriers in children.

Sticky-oil intermediates complicate NAG ligand purification; crystalline Boc intermediates improve handling and support scalable, high-yield poly-NAG synthesis.

A 6′-cyano modification strengthens nuclease resistance while reducing intracellular protein interactions linked to liver and kidney toxicity.

Engineered peptide linkers and species-specific Fc fragments extend insulin activity beyond frequent injections, supporting weekly glucose control in diabetic pets.

Guanidino bridging improves chemical stability and target-strand binding affinity while supporting oligonucleotide production.

Combining CpG-motif oligonucleotides with plasmids and cationic lipids addresses weak single-agent responses by stimulating avian TLR21.

Anhydro-subunit oligosaccharides make prebiotic additives quantifiable in animal feed despite structural similarity to other carbohydrates.

The vinylphosphonic linker stabilizes the mRNA cap conformation, improving eF4E binding, capping efficiency, and translation consistency.

Learn how bifunctional compounds recruit E3 ubiquitin ligases to mark DOT1L for proteasomal degradation in cancer.

Systematic substituent and ring variation in Formula (II) compounds targets CD73 activity across cancer, infections, and neurodegenerative diseases.

Deoxyribonucleic acid kinase phosphorylates fludarabine under mild conditions, while acetate kinase recycles phosphate to reduce by-products and ease purification.

Reference DNA such as ZDHHC1 undergoes the same preparation as marker DNA to normalize methylation in complex stool samples.

Modified oleuropein and oleacein analogues target poor pharmacokinetics and high-dose use through altered chemical structures.

Miglustat paired with glycosylation-optimized recombinant acid α-glucosidase improves Pompe tissue uptake and stability while limiting dosage and immune responses.

Anhydro-subunit markers let mass spectrometry distinguish and quantify oligosaccharide preparations in animal feed despite similar carbohydrates.

Modified rhodamine dyes improve spectral separation for robust multiplex assays using more than six dyes in combination.

Centrifugation captures precipitated mRNA on a porous substrate, enabling 80–95% yields and scalable removal of process contaminants.

Defined oligosaccharide compositions modulate gut microbiota to reduce systemic ammonia in hyperammonemia-related diseases.